Schedule 13G ownership disclosure
CorMedix Inc
Common stock, $0.001 par value · CUSIP: 21900C308
Event date: 2025-11-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 4,955,487.00 · Class: 6.29%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 4,955,487.00 · Class: 6.29%
- David Kroin
Shares: 4,955,487.00 · Class: 6.29%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-005229
- Form type
- SCHEDULE 13G
- Filer
- CorMedix Inc.
- CIK
- CIK 1410098
- Filed
- Dec 01, 2025
- Reporting period
- Nov 21, 2025
- Description
- Schedule 13G beneficial ownership